[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Page 32247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12806]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-10-2021]


Foreign-Trade Zone (FTZ) 49--Newark and Elizabeth, New Jersey; 
Authorization of Production Activity, Celgene Corporation 
(Biopharmaceuticals), Warren and Summit, New Jersey

    On February 12, 2021, Celgene Corporation submitted a notification 
of proposed production activity to the FTZ Board for its facilities 
within Subzone 49U, in Warren and Summit, New Jersey.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 11496, February 25, 2021). On 
June 14, 2021, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: June 14, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-12806 Filed 6-16-21; 8:45 am]
BILLING CODE 3510-DS-P